FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESUFLONAMIDES AS CCR2 MODULATORS FOR THE TREATMENT OF INFLAMMATION

Compounds are provided that act as potent antagonists of the CCR2 receptor. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases and as controls in assays for the identification of CCR2 antagonists...

Full description

Saved in:
Bibliographic Details
Main Authors Wang Qiang, Punna Sreenivas, Ungashe Solomon, Krasinski Antoni, Zeng Yibin
Format Patent
LanguageEnglish
Published 26.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds are provided that act as potent antagonists of the CCR2 receptor. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases and as controls in assays for the identification of CCR2 antagonists.
Bibliography:Application Number: US201615195777